Table of contents

Original research

• Haemorrhagic complications in patients with renal insufficiency during treatment or prophylaxis with dalteparin (12 September, 2020)

  Estrella Díaz Gómez, David Suárez Del Olmo, Laura Corregidor Luna, Irene Iglesias-Peinado, Benito García Díaz
• Effects of pretreatment with terazosin and valsartan on intraoperative haemodynamics in patients with phaeochromocytoma (7 September, 2020)

  Qingrong Ji, Feng Li, Xianzhao Zhang, Yuqiang Wang, Cunfei Liu, Ying Chang
• Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy (31 August, 2020)

  Cangsang Song, Xingde Li, Panpan Mao, Wenbing Song, Lu Liu, Yang Zhang
• Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients (5 October, 2020)

  Shuqiao Cheng, Mimi Tang, Jie Du, Tao Yin
• Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study (13 October, 2020)

  Noelia Fernández-Bargiela, Sandra Rotea-Salvo, Luis Margusino-Framiñán, Vanesa Balboa-Barreiro, Isabel Martín-Herranz, Ángeles Castro-Iglesias, Álvaro Mena-De-Cea, Soledad López-Calvo, Pilar Vázquez-Rodríguez, Enrique Míguez-Rey, Purificación Cid-Silva
• Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements (25 September, 2020)

  Conor Jamieson, Laima Ozolina, R Andrew Seaton, Mark Gilchrist, Tim Hills, F Drummond, Alan Shaun Wilkinson
• Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China (28 September, 2020)

  Na Xu, Jing Xiang Yang, Jian Yang
• Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease (28 October, 2020)

  Nerea Martín-Gutiérrez, José Germán Sánchez-Hernández, Noemí Rebollo, Alejandra F Pordomingo, Fernando Muñoz, María José Otero
• High concentrated etoposide solutions, additional physical stability data in dextrose 5% (20 October, 2020)

  Marine Ravey, Caroline Polo, Elise D'Huart, Jean Vigneron, Béatrice Demoré